Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siltuximab or placebo plus bortezomib and dexamethasone in relapsed or refractory multiple myeloma
2009-017237-22Phase 3Completed
- Sponsor
- Janssen Biologics B.V.
- Start
- Dec 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of siltuximab in multiple myeloma (MM), sponsored by Janssen Biologics B.V.. Started Dec 2010; status: completed.
02
Drugs
siltuximab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2009-017237-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017237-22.